Protease inhibitors, a DNA construct for the expression of a protease and a process for measuring proteases and/or protease inhibitors

摘要

The invention relates to protease inhibitors, particularly metalloprotease inhibitors, for use in treating tissue destructive diseases such as multiple sclerosis, optic neuritis, arthritis and the like and for use in treating cancer; a DNA construct for the expression of the metalloprotease, gelatinase B; and also concerns a process for measuring proteases and/or protease inhibitors.